You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

61 search results for: asthma

How Can FeNO Measurement Improve Severe <b>Asthma</b> Management?
expert video

How Can FeNO Measurement Improve Severe Asthma Management?

Pulmonology
Join Dr. Miguel Lanz as he explains the clinical utility of FeNO as a biomarker of severe asthma.
View more
Concerns Surrounding OCS Side Effects in Patients With Severe <b>Asthma</b>
expert video

Concerns Surrounding OCS Side Effects in Patients With Severe Asthma

Pulmonology
Review the possible consequences of regular oral corticosteroid use in asthma.
View more
Importance of Lung Function Assessment in Adult <b>Asthma</b> Patients
videoanimation

Importance of Lung Function Assessment in Adult Asthma Patients

Pulmonology
Review the burden associated with lung function decline in adult patients with severe asthma, and the value of clinical lung function assessments.
View more
ERS 2024 | Pathophysiologic Mechanisms of Airway Remodeling in Severe <b>Asthma</b>
expert video

ERS 2024 | Pathophysiologic Mechanisms of Airway Remodeling in Severe Asthma

Pulmonology
Professor Celeste Porsbjerg presents the pathophysiology and disease processes involved in airway remodeling in severe asthma.
View more
ADVENT On Air | Diving Deep: Exploring the Impact of Airway Remodeling in Severe <b>Asthma</b>
Podcast

ADVENT On Air | Diving Deep: Exploring the Impact of Airway Remodeling in Severe Asthma

Pulmonology
Join Dr. Mario Castro and Prof. Vibeke Backer as they discuss airway remodeling and airway hyperresponsiveness and their impact in the lives of patients with severe asthma.
View more
What Differentiates COPD Exacerbations From <b>Asthma</b> Exacerbations?
expert video

What Differentiates COPD Exacerbations From Asthma Exacerbations?

Pulmonology
Join global expert Dr. Eric Bateman as he discusses how exacerbations in patients with COPD are different than exacerbations in patients with asthma.
View more
The Risks of Associated Systemic and Atopic Comorbidities with AD
expert video

The Risks of Associated Systemic and Atopic Comorbidities with AD

Dermatology
Dr. Paller explores the multifaceted impact of AD, highlighting its association with various comorbidities such as food allergies, asthma, allergic rhinitis, and mental health disorders.
View more
Clinical Manifestations Associated With Airway Remodeling in <b>Asthma</b>
expert video

Clinical Manifestations Associated With Airway Remodeling in Asthma

Type 2 Inflammation
Join Dr. Hanania to understand how to identify patients at risk of fixed airway obstruction in clinical settings.
View more
ERS 2023 | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​
expert video

ERS 2023 | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​

Pulmonology
Join Profs. Ian Pavord and Vibeke Backer and Dr. Francesca Puggioni for an educational program on the topic of clinical remission in severe asthma.
View more
Why Is It Important to Assess Lung Function in Pediatric Severe <b>Asthma</b> Patients?
expert video

Why Is It Important to Assess Lung Function in Pediatric Severe Asthma Patients?

Pulmonology
Prof. Monika Gappa presents the importance in assessment of lung function in pediatric patients alongside the associated patient burden.
View more
ERS 2023 | Type 2 Biomarkers as Predictive and Prognostic Tools to Guide Management
expert video

ERS 2023 | Type 2 Biomarkers as Predictive and Prognostic Tools to Guide Management

Pulmonology
Prof. Vibeke Backer discusses the predictive and prognostic importance of the various biomarkers of type 2 inflammation in adult asthma.
View more
Type 2 Inflammation Digital Assessment Tool
interactivity

Type 2 Inflammation Digital Assessment Tool

Pulmonology
Learn how to assess patients for the presence of uncontrolled asthma driven by underlying type 2 inflammation.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ItalyChange country/region